
Arbecin100 mcg/ml
Renata Limited
Carbetocin is a synthetic, long-acting analogue of oxytocin indicated for the prevention of postpartum hemorrhage (PPH) caused by uterine atony following delivery of the baby.
Carbetocin is a synthetic, long-acting analogue of oxytocin indicated for the prevention of postpartum hemorrhage (PPH) caused by uterine atony following delivery of the baby.
Carbetocin is not indicated for induction or augmentation of labor and must never be given before delivery of the baby.
Carbetocin is intended for use only by, or under the direct supervision of, a healthcare professional trained in obstetric care, in a setting where uterine tone and vital signs can be monitored.
| Indication | Dose | Route | Timing |
|---|---|---|---|
| Prevention of PPH after cesarean section | 100 micrograms, single dose | Slow intravenous injection over 1 minute (may also be given intramuscularly) | Immediately after delivery of the baby, before delivery of the placenta |
Only one dose of Carbetocin should be given; repeat dosing has not been established as safe or effective and is not recommended. Carbetocin must never be administered before the baby is delivered.
Adverse effects of Carbetocin are generally transient and related to its oxytocic action.
Serious cardiovascular reactions (e.g., significant hypotension, arrhythmia) are uncommon but require prompt medical attention if they occur — see Precautions and Warnings.
Carbetocin is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.